ARTICLE | Company News
Agendia sales and marketing update
June 11, 2012 7:00 AM UTC
Agendia launched its colon cancer recurrence test ColoPrint for stage II colon cancer prognosis and prediction. ColoPrint is a microarray-based 18-gene expression profile. ...